Posted on 1/7/21
Biohaven Acquires Kleo Pharmaceuticals
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the acquisition of the remaining 58% interest of Kleo Pharmaceuticals, Inc. that it did not previously own . . .
Posted on 1/7/21
Werewolf Therapeutics Completes $72 Million Series B Financing
Werewolf Therapeutics, Inc., an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments, today announced the completion of its $72 million Series B financing.
Posted on 1/7/21
Alira Health Acquires Chamow and Associates
Alira Health, a leading international healthcare and life sciences advisory firm, announced it has acquired Chamow and Associates, a California-based integrated CMC
Posted on 1/7/21
LifeMine Therapeutics Raises $50 Million Series B
LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining fungal biodiversity to develop mechanistically and structurally novel therapeutics, today announced a $50 million
Posted on 1/7/21
Scorpion Therapeutics Raises $162M In Series B
Scorpion Therapeutics, Inc., a next-generation precision oncology company, today announced the closing of an oversubscribed Series B financing, which raised $162 million.
Posted on 1/7/21
Berkshire Hathaway Q4 2020 Earnings And Book Value Estimates
SummaryBerkshire lagged the S&P 500 significantly in 2020, gaining 2.4% vs. the S&P 500's total return of 18.4%.Berkshire's equity book gained 13.3% in Q4 to $259.6 . . .
Posted on 1/7/21
bluebird bio Inc., Undervalued Acquisition Candidate
SummaryI estimate the fair value for BLUE between $5-7 billion based on similar acquisitions.2021 could be an inflection point with the anticipated approval of the company's . . .
Posted on 1/7/21
Moderna Coronavirus Vaccine Approved in Europe
Less than a month after winning emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its coronavirus vaccine, Moderna (NASDAQ:MRNA) has scored . . .
Posted on 1/7/21
Generation Bio Prices of Public Offering
CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today . . .
Posted on 1/6/21
Chiasma Provides Corporate Update
NEEDHAM, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral . . .
Posted on 1/6/21
Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
WATERTOWN, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (Nasdaq: ALRN), today announced that it has entered into definitive agreements with fundamental healthcare investors . . .
Posted on 1/6/21
Radius Health Acquires Orphan Disease Program
BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced a definitive agreement to acquire the global development and commercialization rights to Benuvia . . .
Posted on 1/6/21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
WALTHAM, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases . . .
Posted on 1/6/21
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
On Monday evening, Dr. Stephen M. Hahn, director of the Food and Drug Administration, and Dr. Peter Marks, the director of the FDA's Center for Biologics . . .
Posted on 1/5/21
Provident Healthcare Partners Advises Companion Hospice In Its Acquisition By Bristol Hospice
Companion Hospice, a leading hospice and palliative care provider in the Western United States, has had its California operations acquired by Bristol Hospice, a portfolio company . . .
Posted on 1/5/21
Blue Earth Diagnostics Acquires Worldwide Rights to Therapeutic Applications of Scintomics rhPSMA
OXFORD, England & BURLINGTON, Mass.--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that . . .
Posted on 1/5/21
Rhythm Pharmaceuticals Sale of Priority Review Voucher for $100M
Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment
Posted on 1/5/21
The Worst Mistake Moderna Investors Can Make Right Now
In late 2018, Moderna (NASDAQ: MRNA) went public in the largest biotech IPO in history. Its value barely moved until mid-February 2020, when COVID-19 cases in . . .
Posted on 1/5/21
Moderna Lifts Its Estimate for 2021 Coronavirus Vaccine Production by 20%
If all goes according to its revised plan, Moderna (NASDAQ:MRNA) will have far more doses of its coronavirus vaccine on the market than formerly anticipated. The . . .
Posted on 1/4/21
Charles River Laboratories Acquires Distributed Bio
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination
Posted on 1/4/21
Boston Scientific Corporation: Buy This Secular Grower As Elective Procedures Rebound
SummaryBoston Scientific Corporation has demonstrated strong growth under CEO Mike Mahoney and is projected to grow organically at the high end of its peer group.The stock . . .
Posted on 1/4/21
Why Moderna Stock Fell 32% in December
What happenedShares of biotech Moderna (NASDAQ:MRNA), maker of a COVID-19 vaccine, dropped 31.6% in December, according to data from S&P Global Market Intelligence. For context, the . . .
Posted on 1/4/21
EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics
WATERTOWN, Mass., Jan. 03, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 12/23/20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for . . .
Posted on 12/23/20
Sale of Kantar Health Kicks Off Bain Makeover
Global researcher Kantar marked its first year under the control of Bain Capital by selling off its healthcare division to healthcare IT giant Cerner.The price tag . . .
Boston
